1Giovanni B, Domenico R, Gaia S, et al.Analysis of the role of chemokines in angiogenesis. J Immunol Methods, 2003, 273(1 -2):3106-3112.
2Addison CL, Daniel TO, Burdick MD, et al.The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR + CXC chemokine-induced angiogenic activity. J Immunol, 2000, 165(9) : 5269 - 5277.
3Romagnani P, Annunziato F, Lasagni L, et al. Call cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J Clin Invest,2001, 107(1): 53-63.
4Salcedo R, Young HA, Ponce ML, et al. Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3 + endothelial cells. J Immunol, 2001, 166(12) : 7571 - 7578.
5Nor JE, Mitra RS, Sutorik MM, et al. Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway. Vasc Res, 2000, 37(3) :209 - 218.
6Spinetti G, Camarda G, Bernardini G, et al.The chemokine CXCL13 (BCA-1) inhibits FGF-2 effects on endothelial cells. Biochem Biophys Res Commun, 2001, 289(1): 19 -24.
7Bernardini G, Spinetti G, Ribatti D, et al. I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo. Blood, 2000, 96(13): 4039-4045.
8Volin MV, Woods JM, Amin MA, et al.Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis. Am J Pathol, 2001,159(4): 1521- 1530.
9Salcedo R, Resau JH, Halverson D, et al.Differential expression and responsiveness of chemokine receptors ( CXCR1-3 ) by human microvascular endothelial cells and umbilical vein endothelial cells. FASEB J, 2000, 14(13): 2055-2064.
10Salcedo R, Ponce ML, Young HA, et al. Human endothelial cells express CCR2 and respond to MCP-1:direct role of MCP-1 in angiogenesis and tumor progression. Blood,2000, 96(1): 34-40.
8Jaffe EA,Nachman RL,Becker CG,et al.Culture of human endothelial cells derived from umbilical veins identification by morphologic and immunologic criteria[J].J Clin Invest,1973,52(11):2745-2756.
9Bischof M,Abdollahi A,Gong P,et al.Triple combination of irradiation,chemotherapy (pemetrexed),and VEGFR inhibition (SU5416) in human endothelial and tumor cells[J].Int J Radiat Oncol Biol Phys,2004,60(4):1220-1232.
